Dose-ranging, PK, Safety, Efficacy Study of Osanetant in Patients With Moderate/Severe VMS Associated With Menopause
Clinical trial NCT05325775 · COMPLETED
Trial details
- NCT number
- NCT05325775
- Sponsor
- Acer Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-30
- Primary completion
- 2023-03-04
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.